Literature DB >> 3632164

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

P A Wolf, R D Abbott, W B Kannel.   

Abstract

Chronic atrial fibrillation without valvular disease has been associated with increased stroke incidence. The impact of atrial fibrillation on the risk of stroke with increasing age was examined in 5184 men and women in the Framingham Heart Study. After 30 years of follow-up, chronic atrial fibrillation appeared in 303 persons. Age-specific incidence rates steadily increased from 0.2 per 1000 for ages 30 to 39 years to 39.0 per 1000 for ages 80 to 89 years. The proportion of strokes associated with this arrhythmia was 14.7%, 68 of the total 462 initial strokes, increasing steadily with age from 6.7% for ages 50 to 59 years to 36.2% for ages 80 to 89 years. In contrast to the impact of cardiac failure, coronary heart disease, and hypertension, which declined with age, atrial fibrillation was a significant contributor to stroke at all ages.

Entities:  

Mesh:

Year:  1987        PMID: 3632164

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  307 in total

Review 1.  In-hospital approach to newly recognized atrial fibrillation.

Authors:  C D Kimmelstiel; M Homoud; C A Clyne; M Estes III
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

Review 2.  Long-term anticoagulation therapy for atrial fibrillation in elderly patients: efficacy, risk, and current patterns of use.

Authors:  D McCormick; J H Gurwitz; R J Goldberg; J Ansell
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

3.  Managing atrial fibrillation in elderly people.

Authors:  K M English; K S Channer
Journal:  BMJ       Date:  1999-04-24

4.  [Extrabronchial effects of Bronchodilat in patients with asthma and chronic asthmatic bronchitis].

Authors:  J Rozniecki; W Grabski
Journal:  Gruzlica       Date:  1975-11

Review 5.  Very low-intensity antithrombotic therapy in atrial fibrillation.

Authors:  B G Koefoed; P Petersen
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

6.  [Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation].

Authors:  B Leithäuser; F Kasch; T Broemel; J-W Park
Journal:  Herz       Date:  2010-12       Impact factor: 1.443

Review 7.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

Review 8.  Balancing ischaemia and bleeding risks with novel oral anticoagulants.

Authors:  Usman Baber; Ioannis Mastoris; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

9.  Identifying a high stroke risk subgroup in individuals with heart failure.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia J Howard; Virginia G Wadley; Monika M Safford; James F Meschia; Aaron Anderson; George Howard; Elsayed Z Soliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-03       Impact factor: 2.136

Review 10.  Low-dose amiodarone should not be the first-line treatment for atrial fibrillation.

Authors:  R J Sung
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.